Atlas Trials

Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19

Clinical trial NCT04543006 · UNKNOWN

Trial details

NCT number
NCT04543006
Sponsor
University Hospital, Grenoble
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Covid19
Start date
2020-09-08
Primary completion
2021-09-30
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.